Breast milk secrets: stress and sleep may change What's in it
NCT ID NCT06393296
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This Mayo Clinic study looks at how a mother's stress, mood, sleep, and diet might affect levels of melatonin and an immune protein called sIgA in her breast milk. Researchers will follow 120 new mothers who are breastfeeding. The goal is to better understand these connections, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify lifestyle factors that improve breast milk composition, potentially guiding future recommendations for breastfeeding mothers.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all mothers or lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
88 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
New mothers receiving care at Mayo Clinic Health System in Eau Claire, Wisconsin.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Possess a refrigerator with a freezer or a standalone freezer for sample storage at home. * Ability to be contacted by telephone. * Having internet access at home. * Being in the immediate (0-14 days) postpartum period. * Currently breastfeeding or planning to breastfeed, regardless of the type. Exclusion criteria: * Newborns with congenital malformations. * Newborns with birth weights less than 2,500g or greater than 4,000g. * Gestational age less than 37 completed weeks or greater than 42 completed weeks. * Mothers hospitalized in an intensive care unit (ICU). * Newborns hospitalized in the neonatal intensive care unit (NICU) or special care nursery (SCN). * Mothers using sleep aids (e.g., Benadryl, Unisom, Melatonin, Valerian). * Mothers currently being treated for pharmacologically treated mood and sleep disorders. * Mothers with acute infections longer than 7 days postpartum. Mothers will be withdrawn from study if antibiotics are taken between 7 and 14 days postpartum.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breastfeeding are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Health System - Eau Claire
Eau Claire, Wisconsin, 54703, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a wearable sensor read breast fullness and milk flow?
- What shapes breast milk? a deep dive into its composition
- Can a mediterranean diet lift postpartum depression?
- Could listening to success stories boost breastfeeding confidence?
- Can a single drink leave Cancer-Causing compounds in breast tissue?
- Could free diapers and toys boost breastfeeding rates?